MyTrade-Insights

   Breast Implant Market size will exceed $4.9 Billion by 2026, growing at a CAGR of over 10.3% from 2019 to 2026; according to a new research study by Research Dive. An increase in the number of breast augmentation processes, along with the rise in breast cancer incidences across the world will significantly drive the global breast implant market size over the forecast period. The breast augmentation processes enable women to improve their breast size, and also to improve their hip contour balance. These are also called as reconstruction procedures, which help to restore the breasts’ size to near normal size. They also help in improving the appearance of the breasts. Rapid growth in these procedures will significantly spur the global breast implant market growth during the projected timeline. Rapid growth in the incidences of breast cancer across the world will boost the growth of breast implant market growth in the coming years. As a result of this, the majority women are preferring

   According to a recent report published by Research Dive, titled, “Autotransfusion Devices Market by Type, and Application: Global Opportunity Analysis and Industry Forecast, 2018-2027,” the global autotransfusion devices market size was $1,121.5 million in 2018, and is anticipated to reach $1,939.7 million by 2027, at 6.5% CAGR from 2019 to 2027. The North America regional market dominates the global market, followed by Europe, Asia-Pacific, and LAMEA. U.S. dominated the global autotransfusion devices market share in 2018, and is expected to grow at a significant rate during the forecast period. Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of autotransfusion: Blood can be autologously “pre-donated” (termed so despite “donation” not typically referring to giving to one’s self) before a surgery, or alternatively, it can be collected during and after the surgery usi

   According to a new report published by Research Dive, the global animal parasiticide market forecast will be $7,082.2 million by 2026, rising from $5,096.0 million in 2018, and at 4.2% CAGR. The significant animal parasiticide market drivers; are increasing the adoption of pet animal’s and awareness about the importance of parasiticide products to prevent zoonotic diseases. Increasing knowledge among the people about livestock and livestock healthcare, rising the concerns to control of zoonotic diseases in the animals and livestock is anticipated to lead the market growth in the future time. Additionally, increasing investments to develop improved parasiticide products for veterinary healthcare and rise in the expenditure on animal healthcare are further enhancing the animal parasiticide market growth in a positive manner. Parasiticide product cost and heavy R&D investments are projected to hamper the global animal parasiticide market. Animal parasiticide market advancements and

   According to a study of Research Dive, intrathecal drug delivery system market forecast shall surpass $1662 Million by 2027, registering a CAGR of 7.2% from 2019 to 2027. Intrathecal drugs delivery (IDD) system plays the important role in the treatments of intractable (uncontrollable) pain. IDD system utilized for selected patients which are associated with major reduction in quality of health and that have not options of other treatment. This treatment requires highly specialized team for ensuring appropriate selection along with the safety criteria. IDD enables therapist to formulate individualized treatment regimens which can provide improved analgesia with small doses coupled with fewer adverse effects over opioid-based therapies. The major factors that boost the global intrathecal drug delivery system market growth are rising demand for intrathecal drug delivery system for cancer pain. In addition, surge in cost-effective cancer pain treatment using such systems are expected to

   As per study of Research Dive, medical marijuana (cannabis) market forecast revenue of $36,205.4 million in the year 2026 growing at CAGR of 28.7%. Marijuana is more safe and has less severe side effects over other treatment options such as opioid-based treatments. It is more efficient in reducing nausea and also improving appetite among chemotherapy patients. Increasing cancer burden along with rising demand for chronic pain management & treatment is projected to drive the  medical marijuana market growth . For instance, as per publication of the World Health Organization (WHO), in 2018, Cancer disease is the second leading cause of death cases, in which Lung, breast, prostate, liver, stomach and colorectal cancer are the common types of cancerous diseases. Moreover, R&D activities, Clinical trials along with commercialization of cannabis are anticipated to boost the global medical marijuana industry. However, stringent government regulation, lack of awareness in the emergi

   According to a new report published by Research Dive, the global portable oxygen kits market was accounted for $1,372.6 million in 2018, is projected to reach $2,616.8 million by 2026, and at 8.4% CAGR. Growing awareness among the people about prevalence of chronic obstructive pulmonary disease (COPD) and importance of portable oxygen kits while mountain climbing and participating in adventure activities are key drivers for the  portable oxygen kit market growth . As per publication of American Academy of Allergy Asthma and Immunology, around 0.255 million people are suffering with respiratory problems in the world, and is anticipated to increase day by day, due to this, the demand for portable oxygen kit is increasing to diagnose the patients. Furthermore, rising demand of portable oxygen kits from aerospace & automotive industry for drivers and pilots to deliver constant oxygen source in the disaster sites and high speed vehicles is expected to drive the market growth over the

   The healthcare gamification market share is predicted to grow at a CAGR of 11.9% by generating a revenue of $47,281.5 Million by 2026. Gamification includes applying the techniques used in game, mechanics of game, and game style in non-gaming applications to engage the audience and make the dull task into more fun and engaging. Basically it is an application of elements in video games, which helps to solve the everyday problem and enables the user to change the behavior, develop skills and enable innovation in health care. The  goal of the gamification  is to change the behavior of the patient. The increase in the wearables and health & wellness app with gamification is the strong sign that the people are liking it. The increase in the usage of digitalization and the technology adoption are expected to drive the healthcare gamification market. Many companies are using the digital platform for the people to check their health data. For instance, Pokémon go helped the players to i

   Global Antiviral Therapy Market size is expected to grow with a CAGR of 5.8% from 2019 to 2026 According to a study conducted by Research Dive. The global antiviral therapy market size was accounted at $48.1 billion in 2018 and is anticipated to garner $ 75.6 billion by 2026. Increasing incidences of viral infections, growing awareness among public about these infections, rise in healthcare spending, growing R&D investments, and growing incidences of severe and deadly disorders in people are the key  antiviral therapy market  drivers responsible to boost the growth of global market during estimated period. In addition, development of broad-spectrum antibiotics and surge in profitable opportunities in the developing economies of Asia-Pacific and LAMEA regions are expected to provide numerous opportunities for the growth of the market. On the other hand, huge costs involved in the manufacturing of these therapy and rise in the demand for alternative medicines such as homeopathy an

   According to a study of Research Dive, global 3D Cell Culture market forecast shall cross $12,638.8 million by 2026, growing at a CAGR of 29.4 during forecast period. 3D Cell culture is an essential tool in clinical analysis and biological science. It has multiple applications such as in biosensors, drug screening and others. Many improvements have been made in automated high-throughput cell culture systems. Increasing demand for regenerative medicine and economic drug discovery is expected to drive the demand for the 3D cell culture market. 3D cell cultures are primarily used to observe the abnormal behavior of cells and the cell-cell interaction. Furthermore, 3D cell culture systems play a significant role in the development of precision medicine and personalized medicine. For instance, as per study of cancer researchers (University of Michigan) newly invented 3D structure could enable physicians to test medications on model tumors grown from a patient’s own cells. These advances

   Traveling to overseas for affordable and state-of-the-art medical care and treatment is basically termed as medical tourism. Years back, people from developing countries used to travel to highly developed countries seeking advanced and safer treatment, which was barely available in their own countries. Today, people from developed countries travel to developing countries for cost-effective medical treatments, which has slightly changed the traditional concept of medical tourism. The medical tourism market share is predicted to rise at a CAGR of 12.4% and is expected to reach $149.34 Million till 2026. Earlier, in 2018, market was valued $58.62 Billion. Medical tourism means when a person travels to the other country to undergo a treatment. This is usually done by the patient when the medication is more expensive in their respective country or due to the unavailability of advanced medication and machinery in their home country. Basically, medical tourism is the combination of medical

   The global activated partial thromboplastin time test market forecast will surpass $601.2 million by the end of 2026, at a CAGR of 6.8%, and has been rising from $353.0 million in 2018, according to Activated Partial Thromboplastin Time Test Market Analysis by Research Dive. Activated Partial Thromboplastin Time Test Market Trends: Rise in the prevalence of cardiovascular diseases coupled with increase in the demand for thromboplastin test instruments the key drivers for the growth of the activated partial thromboplastin time test market Increase in the adoption of thromboplastin test in the point-of-care diagnostic centers and improvements in the healthcare infrastructure are projected to drive the market growth. The improvements in healthcare infrastructure support the accessibility of test instruments and easy available of coagulation testing devices is anticipated to boost the activated partial thromboplastin time (APTT) test market growth. Furthermore, there is a rise in the bl

   According to a study by Research Dive, the global Airway Management Devices Market forecast size is expected to reach $2,178.8 million by the end of 2026, registering a 7.4% CAGR over the forecast period. Growing occurrence of chronic obstructive pulmonary disease (COPD), predominantly respiratory diseases, along with growing necessity for emergency care, will upsurge the global market. According to the data published by WHO in November 2016 the ‘Global Burden of Disease Study’, around 251 million cases of COPD were registered globally and main causes for their occurrences were long-term asthma, active smoking, and growing indoor air pollution. Moreover, chronic obstructive pulmonary disease incidences are anticipated to grow over the forecast period due to the rise in the aged population and growth in the people smoking globally. Download FREE Sample Copy of the Report at :   https://www.researchdive.com/download-sample/81 Rising number of patients suffering with respiratory issues